Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 63 clinical trials
None
Pharmacokinetics and Pleural Fluid Penetration of Amoxicillin and Clavulanic Acid in Patients With Pleural Infections

is to evaluate the pleural pharmacokinetic of amoxicillin and clavulanic acid in patients with a complicated pleural infection (patients who need a chest tube insertion).

amoxicillin
antibiotic therapy
antibiotics
pleural effusion
clavulanic acid
  • 1 views
  • 24 Jan, 2021
  • 1 location
None
ILTHPI - Comparison of Medicament Containing Tetracycline Metronidazole Bismuth Versus Amoxicillin Metronidazole Clarithromycin

treatment of H. pylori in 2017, the first line therapeutic regiment of H. pylori containing Amoxicillin, Clarithromycin, and Metronidazole if the rate of Clarithromycin resistance is below 15%, while the

  • 0 views
  • 30 Apr, 2021
  • 1 location
None
Comparison Between High-dose Amoxicillin Dual Therapy and Pylera Quadruple Therapy in the Treatment of Helicobacter Pylori Infection

), as the first-line option in areas with significant double resistance to metronidazole and clarithromycin. Another option currently being investigated is the double therapy with amoxicillin in high

Accepts healthy volunteers
antibiotics
adenocarcinoma
gastric adenocarcinoma
endoscopy
  • 0 views
  • 07 Nov, 2021
  • 1 location
None
Study to Compare the Efficacy of Pristinamycin (Pyostacine ®) Versus Amoxicillin in the Treatment of Acute Community Acquired Pneumonia

Primary Objective: To evaluate the clinical efficacy of pristinamycin at a dose of 2g x 2/day for 2 days then 1g x 3/day for 5 to 7 days versus amoxicillin 1g x3 /day for 7 to 9 days, 5

pneumonia
amoxicillin
community acquired pneumonia
procalcitonin
  • 0 views
  • 03 Dec, 2021
  • 14 locations
None
Study to Compare the Efficacy of Pristinamycin (Pyostacine ®) Versus Amoxicillin in the Treatment of Acute Community Acquired Pneumonia

Primary Objective: To evaluate the clinical efficacy of pristinamycin at a dose of 2g x 2/day for 2 days then 1g x 3/day for 5 to 7 days versus amoxicillin 1g x3 /day for 7 to 9 days, 5

fever
cough
chest pain
pneumonia
x-rays
  • 48 views
  • 16 Jan, 2022
  • 73 locations
None
Differences in the Eradication of Helicobacter Pylori by Different Therapies

regimens. The four treatment regimens included (1) Vonoprazan Fumarate + amoxicillin + doxycycline, (2) Vonoprazan Fumarate + furazolidone + doxycycline, (3) esomeprazole + colloidal bismuth tartrate

  • 22 views
  • 12 Nov, 2021
  • 1 location
None
Efficacies of Two Bismuth Quadruple Therapies in the Second-line Treatment of H Pylori Infection

From the profiles of antibiotic susceptibility data following eradication therapy, tetracycline, amoxicillin and levofloxacin are all good candidates of antibiotics used in the rescue treatment

amoxicillin
antibiotic therapy
antibiotics
tetracycline
levofloxacin
  • 0 views
  • 26 Mar, 2021
  • 1 location
None
Study on The Efficacy and Safety of Berberine-containing Triple Therapy in Helicobacter Pylori First-Line Eradication

The purpose of this study is to assess the efficacy and safety of berberine, amoxicillin and vonoprazan containing triple therapy in Helicobacter Pylori first-line eradication. It is

Accepts healthy volunteers
  • 0 views
  • 03 Dec, 2021
  • 1 location
None
Tailored Treatment of H. Pylori Infection Based Polymorphisms of CYP2C19 and 23S rRNA of H. Pylori

The eradication rate of the standard H. pylori eradication therapy (such as the triple therapy with a proton pump inhibitor [PPI], amoxicillin and clarithromycin) depends on bacterial

amoxicillin
lansoprazole
proton pump inhibitors
clarithromycin
helicobacter pylori
  • 37 views
  • 07 Nov, 2020
  • 1 location
None
Bismuth-Metronidazole Triple Therapy for H. Pylori First-line Treatment

therapy (PPI+bismuth+ metronidazole+ amoxicillin) for Helicobacter pylori first-line treatment. The completion of this trial will expand new therapy for the treatment of Helicobacter pylori, which can not

  • 0 views
  • 28 Jan, 2021
  • 1 location